The CPNP Foundation supports the Defining the Future Grant Program designed specifically for students/CPNP student chapters, residents, and fellows interested in psychiatric and neurologic pharmacy. This is an excellent opportunity to receive funding for a research project that will help define the future of neuropsychiatric pharmacy practice and improve the care of patients with psychiatric and neurologic disorders.
To create a competitive selection process challenging students and residents to research innovative and cutting-edge practices that will impact the care of patients into the future, to share this work within the field of pharmacy, and to provide financial support to achieve these outcomes.
Submitted applications must be consistent with the vision and mission of the Foundation. Grantees will be required to obtain IRB approval prior to starting their project. Grantees will also be required to submit an abstract of their research for poster consideration and, if selected, present their research results as a poster at the 2018 CPNP Annual Meeting to be held April 22-25 at the JW Marriott in Indianapolis, Indiana.
The CPNP Foundation grant committee will select recipients after rating all applications on the following criteria:
Grant applications are accepted annually May-August, and up to three applicants are awarded $1500 each to fund their research project and poster presentation. Depending on the number of suitable applications, not all the grants may be awarded.
As a requirement of grant, the 2016 grant recipients submitted their research abstracts for poster consideration at the 2017 CPNP annual meeting in Phoenix, Arizona. All four abstracts were accepted, and a PDF of each poster is available to view.
Andrew Kluemper, PharmD, University of Colorado Health & Anschutz and Lowry Internal Medicine Clinics, will conduct a project entitled “Effect of Primary Care Provider Stigma on Appropriate PHQ-9 Administration.”
The goal of this research was to find out if stigma influences depression management (screening, severity assessment, and treatment) in the primary care setting. To do this, the researcher 1) Characterized PCP stigma related to depression, and 2) Evaluated the relationship between provider stigma and appropriate Patient Health Questionnaire 9 (PHQ-9) administration.
Jenni Ladutko, PharmD*, Veterans Administration Salt Lake City Healthcare System, will complete her project entitled “Implementation of a PolyphArmacy Clinic in Vulnerable Elders (PAVE Clinic) Within an Integrated Patient Aligned Care Team.”.
The goal of this study was to implement and evaluate the outcomes of a novel, pharmacy run, polypharmacy clinic for patients 75-95 years old within the outpatient Patient Aligned Care Teams (PACT). The purpose of this research was to benefit patient care by giving providers a comprehensive medication review by a pharmacist that assesses medication appropriateness and provides recommendations for overall care.
*2017 CPNP Foundation Strategic Goals Award recipient
Samantha Themas, PharmD, Memorial Outpatient Behavioral Health Center, will research “Effect of Clinical Pharmacy Specialist Intervention on Metabolic Markers in Patients Receiving Long-acting Antipsychotic Injections.”
The purpose of this study was to assess the impact of a clinical pharmacy specialist-managed long-acting antipsychotic injection clinic on patient outcomes. The goal was to establish a long acting therapy (LAT) clinic in a hospital ambulatory setting that promotes a team-based approach to patient care, comprehensive monitoring of medication side effects and metabolic issues, and improved patient access to expert, integrated care.
Tu Vuong, PharmD student from University of Southern California, will assess “Incorporating Clinical Pharmacy Service into Depression Management at a Primary Care Clinic.”
The goal of this study was to incorporate clinical pharmacy services into depression management at a primary care clinic. The researcher will develop a depression care protocol, implement the protocol at the Keck Family Medicine clinic with a supervising pharmacist and physician, conduct a patient/provider/staff satisfaction survey, and analyze the results to evaluate the impact of this program.
Lauren J. Heath, PharmD: Influence of Patient Stigma on Depression Remission